Skip to main content

Vivani Medical, Inc. (VANI)

Sector
Healthcare
Industry
Biotechnology
Last price
$1.05
As of

Kresmion compiles this page from VANI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Vivani Medical, Inc. (VANI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.

As of . Source: SEC EDGAR filings for VANI. Method and limitations.

COMPANY DOSSIER

See the full VANI dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for VANI on one page. Preview it with sample data, then open it live with a free account.

Preview the VANI dossier

Active events for VANI

  • mediumEarnings above estimates

    Q3-2026: Beat consensus by 5.9%, EPS $-0.08 vs $-0.085 estimate

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 17.6%, EPS $-0.07 vs $-0.085 estimate

  • high13F: large reduction

    RENAISSANCE TECHNOLOGIES LLC cut 62% of VANI (2026Q1)

  • mediumEarnings below estimates

    Q2-2025: Missed consensus by 17.6% - EPS $-0.12 vs $-0.102 estimate

  • mediumEarnings above estimates

    Q4-2025: Beat consensus by 11.8% - EPS $-0.09 vs $-0.102 estimate

FREE, NO ACCOUNT

Every event on VANI, as it fires

You are seeing 5 of 7 events recorded on VANI since 2026-05-29.

The five above landed across 4 days. The other 2 were recorded on 1 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, VANI

Going concern statement

VANI's 10-Q filed Nov 12, 2026 states:

These conditions raise substantial doubt about our ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on VANI

VANI mentioned in Kresmion daily briefs

VANI against its peers

VANI's return on equity of -169.2% ranks in the 21st percentile of 20 Biotechnology sub-industry peers, fiscal periods ending between 2025-01-31 and 2025-12-31.

MetricVANIPeer medianPercentilen
Revenue FY0.0 USD3.6M USD1315
Operating marginn/a-263.1%n/a12
Net marginn/a-63.4%n/a12
Return on equity-169.2%-60.5%2120
1 year-24.4%-36.9%5922

Peers (23): CBUS, BETRF, TVGN, ICCC, NRXP, VXRT, ANIX, HURA, XGN, AVXL, PMVP, RLYB, UNCY, NKTX, VTVT, BDTX, GNLX, PLYX, CUE, CHRS, NMRA, ORGO, NBP. Left out: RTSN (no annual filing), OTLK (no annual filing). Fiscal periods ending between 2025-01-31 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (VANI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in VANI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on VANI in the last 180 days.

Upstream: SEC EDGAR filings for VANI

Kresmion, "Vivani Medical, Inc. (VANI) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/VANI. Upstream data: SEC EDGAR filings for VANI.

Link to this data (HTML):

<a href="https://kresmion.com/research/VANI">Vivani Medical, Inc. (VANI) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow VANI on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to VANI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the VANI dossier
Share

The VANI intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.